Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1low HCV-Specific CD8+ Cell Reactivity.
Moreno-Cubero E, Subirá D, Sanz-de-Villalobos E, Parra-Cid T, Madejón A, Miquel J, Olveira A, González-Praetorius A, García-Samaniego J, Larrubia JR. Moreno-Cubero E, et al. J Virol. 2018 Jan 2;92(2):e01443-17. doi: 10.1128/JVI.01443-17. Print 2018 Jan 15. J Virol. 2018. PMID: 29093082 Free PMC article.
Letter: the probability to predict HBV-specific CD8+ cell response derived from HLA-A2+ may not foresee the functional cure well in Asian off-therapy cohort-authors' reply.
Peña-Asensio J, Calvo H, Miquel J, Sanz-de-Villalobos E, González-Praetorius A, Torralba M, Larrubia JR. Peña-Asensio J, et al. Among authors: gonzalez praetorius a. Aliment Pharmacol Ther. 2022 Oct;56(8):1312-1313. doi: 10.1111/apt.17212. Aliment Pharmacol Ther. 2022. PMID: 36168258 No abstract available.
Bim-mediated apoptosis and PD-1/PD-L1 pathway impair reactivity of PD1(+)/CD127(-) HCV-specific CD8(+) cells targeting the virus in chronic hepatitis C virus infection.
Larrubia JR, Benito-Martínez S, Miquel J, Calvino M, Sanz-de-Villalobos E, González-Praetorius A, Albertos S, García-Garzón S, Lokhande M, Parra-Cid T. Larrubia JR, et al. Cell Immunol. 2011;269(2):104-14. doi: 10.1016/j.cellimm.2011.03.011. Epub 2011 Mar 17. Cell Immunol. 2011. PMID: 21481848
Infectious Keratitis: Microbiological Review of 297 Cases.
Tena D, Rodríguez N, Toribio L, González-Praetorius A. Tena D, et al. Jpn J Infect Dis. 2019 Mar 25;72(2):121-123. doi: 10.7883/yoken.JJID.2018.269. Epub 2018 Oct 31. Jpn J Infect Dis. 2019. PMID: 30381686 Free article.
Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain.
Treviño A, Aguilera A, Caballero E, Benito R, Parra P, Eiros JM, Hernandez A, Calderón E, Rodríguez M, Torres A, García J, Ramos JM, Roc L, Marcaida G, Rodríguez C, Trigo M, Gomez C, de Lejarazu RO, de Mendoza C, Soriano V; HTLV Spanish Study Group. Treviño A, et al. Virol J. 2012 Mar 23;9:71. doi: 10.1186/1743-422X-9-71. Virol J. 2012. PMID: 22444832 Free PMC article.
Changes in the epidemiology of hepatitis A: Clinical and preventive implications.
Martínez Ramírez NM, González Praetorius A, Martínez Benito Y, García Rivera MV, Caballero López B, Torralba González de Suso M. Martínez Ramírez NM, et al. Among authors: gonzalez praetorius a. Gastroenterol Hepatol. 2023 Feb;46(2):116-123. doi: 10.1016/j.gastrohep.2022.07.003. Epub 2022 Aug 11. Gastroenterol Hepatol. 2023. PMID: 35964810 English, Spanish.
63 results